Project leads
Collaborators

Prospective Study of Serum MIS and Gynecologic Cancer Risk

Joanne F Dorgan

5 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Follow

Collaborator from New York University

New York University

New York, United States

Vittorio Krogh

Cairo University

Giza, Egypt

Istituto Nazionale dei Tumori (IRCCS)

Milan, Italy

Theron Johnson

German Cancer Research Center (HZ)

Heidelberg, Germany

Naomi Allen

University of Oxford

Oxford, United Kingdom

Annika Idahl

Umeå University

Umeå, Sweden

Joanne F Dorgan

University of Maryland, Baltimore

Baltimore, United States

Related projects

Kathleen E Malone

Epidemiology of the four most frequent cancers following breast cancer

Multiple Myeloma Study / Histological Classification and Clinical Course of Surface Epithelial Ovarian Tumors in Abuja

Hematology and hematologic malignancies Pathology

Joanne S. Richards

Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis

Bryan Q Spring

Online monitoring and image-guided treatment of chemoresistant micrometastases

Linda S Cook

Mitochondrial DNA and Ovarian Cancer Risk and Survival

Shelley S Tworoger

Psychological Stress, Associate Biologic Mediators, and Ovarian Cancer Risk

Kunle O Odunsi

mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity

Richard R Barakat

The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors, and Impact

Surgery / Surgical oncology

Kunle O Odunsi

RPCI-UPCI Ovarian Cancer SPORE